| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | $99,2800 | -2,17% | $1,44B | $351,48K | |
TMP Tompkins Financial Corporation | $97,1200 | +0,05% | $1,44B | $43,66K | |
BRUN Boost Run Inc. Class A Common Stock | $19,3950 | +2,03% | $1,44B | $1,44M | |
TWFG TWFG, Inc. Common Stock | $28,4400 | +3,57% | $1,44B | $126,81K | |
PCT PureCycle Technologies, Inc. Common stock | $6,7500 | -5,86% | $1,44B | $4,80M | |
REX REX American Resources Corp. | $44,3900 | +1,19% | $1,43B | $141,19K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | $7,3100 | -5,68% | $1,43B | $44,04K | |
BTT BlackRock Municipal 2030 Target Term Trust | $22,5100 | -0,57% | $1,43B | $55,63K | |
ADNT Adient plc Ordinary Shares | $19,4900 | -0,71% | $1,43B | $557,82K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | $26,9900 | -0,04% | $1,43B | $1,83M | |
| $35,5505 | -4,46% | $1,43B | $1,25M | |
EMAT Evolution Metals & Technologies Corp. Common Stock | $3,3600 | +17,90% | $1,43B | $1,12M | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | $16,8600 | +1,26% | $1,42B | $66,02K | |
REPL Replimune Group, Inc. | $14,0400 | -5,20% | $1,42B | $4,27M | |
HCSG Healthcare Services Group | $22,9800 | +0,22% | $1,42B | $747,22K | |
